These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
837 related articles for article (PubMed ID: 26690371)
21. ΔNp63α attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma. Zhao W; Wang H; Han X; Ma J; Zhou Y; Chen Z; Zhou H; Xu H; Sun Z; Kong B; Fang H Tumour Biol; 2016 Aug; 37(8):10621-32. PubMed ID: 26864590 [TBL] [Abstract][Full Text] [Related]
22. S-Nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma. Kaliyaperumal K; Sharma AK; McDonald DG; Dhindsa JS; Yount C; Singh AK; Won JS; Singh I Redox Biol; 2015 Dec; 6():41-50. PubMed ID: 26177470 [TBL] [Abstract][Full Text] [Related]
23. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells. Zhang C; Guo F; Xu G; Ma J; Shao F Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024 [TBL] [Abstract][Full Text] [Related]
24. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis. Yu CC; Chen PN; Peng CY; Yu CH; Chou MY Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999 [TBL] [Abstract][Full Text] [Related]
25. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis. Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116 [TBL] [Abstract][Full Text] [Related]
26. microRNA-203 suppresses invasion of gastric cancer cells by targeting ERK1/2/Slug/ E-cadherin signaling. Gao P; Wang S; Jing F; Zhan J; Wang Y Cancer Biomark; 2017; 19(1):11-20. PubMed ID: 28269747 [TBL] [Abstract][Full Text] [Related]
27. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1. Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682 [TBL] [Abstract][Full Text] [Related]
28. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma. Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539 [TBL] [Abstract][Full Text] [Related]
29. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways. Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro. Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460 [TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma. Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980 [TBL] [Abstract][Full Text] [Related]
32. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis. Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854 [TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA MEG3 decreases the growth of head and neck squamous cell carcinoma by regulating the expression of miR-421 and E-cadherin. Ji Y; Feng G; Hou Y; Yu Y; Wang R; Yuan H Cancer Med; 2020 Jun; 9(11):3954-3963. PubMed ID: 32277605 [TBL] [Abstract][Full Text] [Related]
34. Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane). Chakravarti N; Myers JN; Aggarwal BB Int J Cancer; 2006 Sep; 119(6):1268-75. PubMed ID: 16642480 [TBL] [Abstract][Full Text] [Related]
35. Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway. Kong G; Jiang Y; Sun X; Cao Z; Zhang G; Zhao Z; Zhao Y; Yu Q; Cheng G Oncol Rep; 2017 Nov; 38(5):2647-2656. PubMed ID: 29048621 [TBL] [Abstract][Full Text] [Related]
36. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma. Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493 [TBL] [Abstract][Full Text] [Related]
37. Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma. Chen C; Zimmermann M; Tinhofer I; Kaufmann AM; Albers AE Cancer Lett; 2013 Sep; 338(1):47-56. PubMed ID: 22771535 [TBL] [Abstract][Full Text] [Related]
38. p70S6K promotes IL-6-induced epithelial-mesenchymal transition and metastasis of head and neck squamous cell carcinoma. Wu D; Cheng J; Sun G; Wu S; Li M; Gao Z; Zhai S; Li P; Su D; Wang X Oncotarget; 2016 Jun; 7(24):36539-36550. PubMed ID: 27174914 [TBL] [Abstract][Full Text] [Related]
39. MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines. Farina FM; Inguscio A; Kunderfranco P; Cortesi A; Elia L; Quintavalle M Cell Death Dis; 2017 Jun; 8(6):e2890. PubMed ID: 28640256 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2. Ma DN; Chai ZT; Zhu XD; Zhang N; Zhan DH; Ye BG; Wang CH; Qin CD; Zhao YM; Zhu WP; Cao MQ; Gao DM; Sun HC; Tang ZY J Hematol Oncol; 2016 Jan; 9():1. PubMed ID: 26733151 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]